Alain Simard, PhD
Dr. Simard received his PhD from l’Université Laval in Québec City, Canada. His thesis project involved studying the role of microglial cells in various neurodegenerative disease models (including Alzheimer’s disease). Since completing his PhD in 2006, he has pursued postdoctoral studies at Barrow Neurological Institute. He is conducting joint projects with the laboratories of Drs. Lukas (Neurochemistry Lab) and Shi on the role of nicotinic acetylcholine receptors in mediating the anti-inflammatory properties of nicotine in a mouse model of multiple sclerosis. Dr. Simard’s work has been supported by postdoctoral fellowships from the Canadian Institutes of Health Research and the Multiple Sclerosis Society of Canada. In his spare time, Dr. Simard enjoys hockey, running, hiking, cooking and reading.